PainGenie LtdPortland House
8 Offington Drive
Worthing
West Sussex, BN14 9PN, United Kingdom, 0845 6800078, sales@paingenie.netClinical studieshttp://www.paingenie.net13:54 10-Sep-2010
The downloads below are statistics, studies and clinical trials produced at Universities, hospitals and teaching hospitals. Compiled in Australia, Russia, Germany, Canada and the USA.
 |
pain_genie_biocontrollable_electrostimulation_in_clinics_of_nervous_diseases.pdf - 121kb Download this file |
Please click on the
attachments above to see some clinical studies conducted in Russia, Australia, Germany and neuro-peptide research from Canada/US (The Pain Genie Scenars biofeedback mechanism allows the massive release of these 'nerve-chemicals'). Results of further clinical trials from the UK and Gemany are expected to be added sometime in 2010 together with results taken from pain management clinics in Europe, Asia and America.
ABSTRACTS OF CLINICAL TESTS - Russian Health Ministry.
Health Ministry of the Russian Federation.
Burdenko Neurosurgery Institute.
The device was applied to patients with
post-cerebrospinal traumas (ranging in age from 6 months to 4 years), with
extremity paresis, pelvis disorders, and sore spots.All patients experienced increased activity in
their extremities, and pain was either reduced or entirely eliminated. Patients
with urinary disorders also improved. Without any special treatment of
additional zones, cardio-vascular and digestive functions were normalized.
Approved by Deputy Director of Scientific
Research Professor, F.A. Serbienko.
Russian Health Ministry. Scientific Research Institute of Pediatrics and Infantile Surgery.
At the Pediatric Psychoneurology Department,
medical tests were conducted with children from 4 months to 3 years old, with
arrested motor development and post-delivery trauma.In all cases, there was a positive response.
Children became more active, emotionally balanced, and growth disorders
decreased. Patients did not have an adaptive response to treatment, so results
were optimal.
Approved by Professor Y.E. Weltishchev,
Director.
Russian Health Ministry. Russian Scientific Research Institute of Traumatology and Orthopedics.
Scenar was used on a group of post-surgical
bones and joints patients. All patients experienced reduced edema of operated
limbs, fast relief of inflammatory effects, and fistula closures. Patients with
algetic and radicular syndrome experienced fast pain relief and overall
improvement.
Approved by Professor N.V. Kornilov, Director.
Russian Health Ministry. Academician I.P. Pavlov State Medical University, St. Petersburg.
Research was conducted for three months, Dec.
1997 through Feb. 1998, in the Fourteenth Child Health Center of the Petrograd
District of St. Petersburg, by the Pediatrics Chair Research Workers. Twenty
five children suffering from the night-time bedwetting were totally cured
during the clinical tests. Children with urologic enuresis were not included in
the group. Every child received 4-10 sessions weekly. In all cases the results
were positive: enuresis stopped completely or episodes became solitary.
Enuresis treatment with the SCENAR Therapy can be recommended for ambulatory
practice.
Approved by doctor O.K. Moskvichev, Head of
Pediatrics Chair.
Russian Health Ministry. Central Military Scientific and Research Aviation Hospital.
Scenar was applied to a group of patients
suffering from spinal column and joints problems, lesions of central and
peripheral nervous system of different degrees, growth and trophic disorders,
pain and surface sensitivity. In all cases quick relief of pain and symptoms
was observed, more pronounced under acute processes. Positive organism's reaction
as the response at instrument (apparatus) exposure, are still go on for some
days after it's application.
Approved by hospital's head on research, candidate of medical science
A.P. Kozlovsky.
|